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In this study, we investigate how neurosteroid sensitivity of GABAA receptors (GABAARs) is regulated. We examined this issue in neurons
of the supraoptic nucleus (SON) of the rat and found that, during parturition, the GABAARs become insensitive to the neurosteroid
allopregnanolone attributable to a shift in the balance between the activities of endogenous Ser/Thr phosphatase and PKC. In particular,
a constitutive endogenous tone of oxytocin within the SON after parturition suppressed neurosteroid sensitivity of GABAARs via activa-
tion of PKC. Vice versa before parturition, during late pregnancy, application of exogenous oxytocin brings the GABAARs from a
neurosteroid-sensitive mode toward a condition in which the receptors are not sensitive. This indicates that there may be an inverse
causal relationship between the extent to which the GABAAR or one of its interacting proteins is phosphorylated and the neurosteroid
sensitivity of the GABAAR. Neurosteroid sensitivity was not affected by changes in subunit composition of GABAARs known to occur
concurrently in these cells.
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Introduction
The neurosteroid allopregnanolone [(5-pregnan-3-ol-20-one
(3-OH-DHP)] is a potent endogenous allosteric modulator of
GABAA receptors (GABAARs) (Twyman and MacDonald, 1992)
acting via a specific binding domain (Turner et al., 1989; Lambert
et al., 1995). Variation in the efficacy of neurosteroids to modu-
late GABAARs, as observed in different types of neurons (Harri-
son et al., 1987; Zhu et al., 1996; Brussaard et al., 1997, 1999;
Cooper et al., 1999), has been proposed to arise from differences
in subunit composition of the GABAARs. Despite previous at-
tempts to identify the specific GABAAR subunits that mediate
neurosteroid effects, no adequate explanation for the apparent
correlation between diversity in receptor subtype and neuroste-
roid sensitivity has been put forward (Belelli et al., 1996; Zhu et
al., 1996; Brussaard et al., 1997; Davies et al., 1997; Smith et al.,
1998a,b). Moreover, recent studies indicate that phosphorylation
may affect neurosteroid modulation of recombinant (Leidenhei-
mer and Chapell, 1997) and native (Fancsik et al., 2000)
GABAARs. The latter study suggested that PKC-mediated phos-
phorylation is a prerequisite for neurosteroid regulation by
showing that, in supraoptic nucleus (SON) neurons, the
G-protein blocker GDP--S and the PKC antagonist bisindolyl-
maleimide both prevented an effect of subsequent 3-OH-DHP
treatment on the decay of IPSCs.
However, additional research is necessary because (1) the
pharmacological agents used by Fancsik et al. (2000) to manipu-
late phosphorylation had an effect on the IPSC decay in the ab-
sence of neurosteroid, (2) pharmacological activation of
G-protein signaling or PKC activity did not potentiate the effect
of 3-OH-DHP on GABAARs (Fancsik et al., 2000), and (3) hith-
erto it remained unclear what mechanism underlies the occur-
rence of neurosteroid-insensitive GABAARs in oxytocin (OT)
neurons in the SON after parturition and of GABAARs being
highly sensitive to neurosteroid during late pregnancy (Brussaard
et al., 1997). The latter issue may be relevant because robust
regulation of the endogenous PKC activity in SON neurons is
likely to occur after, but not before, parturition (Brussaard et al.,
2000) attributable to increased levels of oxytocin (Lambert et al.,
1994; Leng et al., 1999). In addition, the oxytocin neurons in the
SON were shown to shift between a major role for1- during late
pregnancy toward 2-containing GABAARs after parturition
(Brussaard et al., 1997, 1999). Thus, the exact role of PKC activity,
or of any other intracellular enzyme, in conditioning the neuro-
steroid sensitivity of GABAARs in the SON is still unclear.
Therefore, using the SON during the female reproduction cy-
cle as a model, we aimed at explaining the endogenous shift be-
tween different modes of neurosteroid sensitivity of GABAAR
activity. We also used a transgenic1/ knock-out mouse (Sur
et al., 2001), which excluded a prominent role for changes in
GABAAR subunit composition in the modulation of neuroste-
roid sensitivity. Instead, we provide a cellular mechanism that
explains how GABAARs may switch their mode of neurosteroid
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sensitivity and that is also fully consistent with all observations on
neurosteroid sensitivity of GABAARs that have been reported
previously in the SON under natural conditions (Brussaard and
Herbison, 2000).
Materials and Methods
Recombinant expression of GABAARs
Transfection and membrane preparation. Expression vectors for the , ,
and 2L subunits from rat were transfected in triple combination into
human embryonic kidney cells (HEK 293; American Type Culture Col-
lection CRL 1573) as described previously (Lu¨ddens and Korpi, 1995).
For optimal receptor expression, final concentrations (in g of vector
DNA per 15 cm tissue culture plate) were as follows: 5 1, 12 2, 25 2,
and 0.5 2S. The 2S variant is abbreviated 2 in the remainder of the
text. Cells were washed 40 hr after transfection with PBS, pH 7.4, at 37°C,
harvested in ice-cold PBS, and centrifuged at 500 rpm. Cell pellets were
homogenized in an Ultraturrax homogenizer for 15 sec, pelleted at
20,000 rpm, frozen at20°C, and recentrifuged. The membrane pellets
were resuspended in 50 mM Tris– citrate buffer, pH 7.3.
Binding assays. Resuspended cell membranes (50 –200 g of protein
per tube) were incubated in a final volume of 0.5 ml of 50 mM Tris– citrate
buffer, pH 7.3, supplemented with 0.2 M NaCl for [ 35S]t-butylbicyclo-
phosphothionate (TBPS) (2– 6 nM) binding. GABA was diluted from a
100 mM solution in H2O. Nonspecific binding was determined by 20 M
picrotoxin. After 90 min at room temperature, the assay mixtures were
rapidly diluted to 5 ml with ice-cold 10 mM Tris–HCl, pH 7.4, filtered
through glass fiber filters and washed once with 5 ml of 10 mM Tris–HCl,
pH 7.4. Filters were immersed in 4 ml of Packard Ultima Gold scintilla-
tion fluid, and the radioactivity was determined in a Beckman Instru-
ments (Fullerton, CA) liquid scintillation counter using external stan-
dardization. Statistical calculations were performed using the Graph Pad
Prism program (GraphPad Software, San Diego, CA).
Receptor expression in Xenopus oocytes. Expression, drug application,
and two-electrode voltage-clamp experiments were performed as de-
scribed previously (Zwart and Vijverberg, 1997). Rat GABAAR 1, 2,
2, and 2L subunit cDNAs, ligated into the VMT expression vector,
were kindly provided by Dr. Paul Whiting (Merck, Sharp, and Dohme,
Harlow, UK). Plasmids coding for the , , and  subunits of GABAARs,
dissolved in distilled water at a 1:1:1 molar ratio, were coinjected into the
nuclei of stage VI oocytes. Approximately 1 ng of each plasmid contain-
ing , , and  cDNA was injected in a total injection volume of 15–20
nl/oocyte. Experiments were performed on oocytes after 2–5 d of incu-
bation in modified Barth’s solution. Oocytes were voltage clamped at
80 mV. Aliquots of freshly prepared, concentrated stock solutions of
GABA in distilled water and of 3-OH-DHP in dimethylsulfoxide
(DMSO) were added to the recording solution immediately before the
experiments. Drug applications were alternated by 5 min of superfusion
with agonist-free saline to allow the receptors to recover from
desensitization.
Mouse model and quantitative PCR
Generation of 1/ mice. The GABAAR 1 gene-targeting vector was
constructed from the genomic 129/SvEv  fixII clone, which has been
used for the introduction of the 1H101R mutation. However, for the
complete gene knock-out, exon 4 was disrupted at the MscI restriction
site by cloning the 1.2 kb BstBIMscI and the 7 kb EcoRVBamHI DNA
fragment blunt ended into the targeting vector (Sur et al., 2001). For this
study, the F5 generation was used.
Quantative PCRs. Primers for quantitative-PCR (Q-PCR) analysis of
various GABAAR subunit mRNAs were designed using the Primer Ex-
press program (version 1.0; Applied Biosystems, Foster City, CA). Total
RNA was isolated from SON punches obtained from slices of individual
wild-type (WT) and 1/ animals after the recording session, reverse
transcribed into cDNA, and used as template in a Q-PCR experiment.
-Actin mRNA levels were measured as an internal standard. The ABI
7700 Sequence Detection System (Applied Biosystems) was used with
cyber green as the reporter dye.
Whole-cell voltage-clamp recordings of SON neurons of mice
and rats
For this study, 202 neurons were recorded from the dorsomedial SON,
which contains mostly oxytocin cells (Hou-Yu et al., 1986). In experi-
ments involving oxytocin application, all cells responded to the peptide.
After parturition, all cells recorded under control conditions were neu-
rosteroid insensitive (Brussaard et al., 1997), possibly indicative of an
oxytocinergic nature. Adult female WT and 1 / mice, as well as
juvenile male (21–24 d postnatal) or adult female Wistar rats, either after
20 d of pregnancy (P20), or on postparturition day 1 (PPD1) were de-
capitated, and 400-m-thick coronal hypothalamus slices incorporating
the middle portion of the SON were prepared using a Leica (Nussloch,
Germany) vibratome slicer. The external solution contained the follow-
ing (in mM): 125 NaCl, 25 NaHCO3, 3 KCl, 1.2 NaH2PO4H2O, 2.4
CaCl22H2O, 1.3 MgSO47H2O 1.3, and 10 D()-glucose (304 mOsm,
carboxygenated in 5% CO2–95% O2, pH 7.4). DNQX and AP-5 (both at
20 M; Research Biochemicals, Natick, MA) were continuously present.
The pipette solution contained the following (in mM): 140.5 CsCl, 10
HEPES, 2 MgATP, and 0.1 GTP (acid free), adjusted to pH 7.2 using
CsOH (296 mOsm) and no EGTA or Ca 2 (i.e., “unbuffered” pipette
medium), unless mentioned otherwise. Spontaneous GABAergic synap-
tic currents (sIPSCs) were recorded at room temperature (20°C), unless
mentioned otherwise, at a holding potential of 70 mV with an Axo-
patch 200A amplifier (Axon Instruments, Foster City, CA) in the whole-
cell voltage-clamp mode. For recording criteria for selection of cells, see
Brussaard et al. (1996). Recorded sIPSCs were not sensitive to TTX or
nominal zero extracellular Ca 2, and bicuculline (20 M; Research Bio-
chemicals) blocked all remaining synaptic activity (Brussaard et al., 1996,
1999). The sIPSCs had a decay that was best fitted with a single-
exponential function. Applications were performed via a home-made
so-called Y-tube microperfusion system (Brussaard et al., 1996). Oxyto-
cin effects were effectively blocked by a specific oxytocin antagonist,
d(CH2)
5-OVT (dOVT) (Bachem, Bubendorf, Switzerland). 3-OH-
DHP was obtained from Research Biochemicals, dissolved in DMSO at
10 mM, and further diluted in external solution before application (10
M). The lipophylicity of this substance prevents accurate estimates of
the final concentration of 3-OH-DHP at the site of action, as has been
extensively discussed previously (Brussaard et al., 1997, 1999). Recorded
cells were in the second layer of neurons below the slice surface (50m
deep). The effect of 3-OH-DHP in all recordings was determined dur-
ing a 3 min period of recording starting 2 min after neurosteroid appli-
cation. 12-O-Tetradecanoylphorbol-13-acetate (TPA) (PMA is phorbol
12-myristate 13-acetate), okadaic acid, microcystin, and chelerythrine
were all from Research Biochemicals; C2-ceramide (N-acetyl-d-erythro-
sphingosine) was obtained from Calbiochem (La Jolla, CA). For experi-
ments using okadaic acid, microcystin, and chelerythrine, which were in
the pipette solution only, 3-OH-DHP was applied after 8 min of “pre-
treatment” recording. TPA and C2-ceramide were applied extracellularly
3 min after the whole-cell configuration was established and after this 8
min pretreatment period 3-OH-DHP was applied.
Analysis of synaptic currents
Digital detection of sIPSCs, amplitude analysis, and curve-fitting proce-
dures to quantify the decay rate of individual sIPSCs have all been de-
scribed previously (Brussaard et al., 1996, 1997, 1999). Per experiment
and per condition, an unimodal lognormal function was fitted to histo-
grams of binned data (either amplitude or decay time constants) ob-
tained from a minimum of 250 sIPSCs per histogram. Average values
thus obtained for control–pretreatment conditions and after neuroste-
roid application were compared using the paired t test. Control and
pretreatment conditions of different experiments were compared using
the unpaired t test. In some experiments, nonparametric testing was
performed using the Mann–Whitney U test. In all summary figures in
which overall changes in sIPSC decay have been quantified, statistical
significance has been indicated using *p 0.05 and **p 0.01. Data are
reported as the mean SEM.
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Results
Recombinant expression of GABAARs
To compare the sensitivity of 1- versus 2-containing
GABAARs we expressed recombinant GABAARs in HEK 293 cells
and in oocytes
In HEK 293 cells, we found that GABA at 1M is slightly more
potent in inhibiting the binding of [ 35S]TBPS to 122L than
to 222L receptors (reduction to 45  7 and 70  13% of
control [ 35S]TBPS binding, respectively) (Fig. 1), which is in line
with previous results (Lu¨ddens and Korpi, 1995). In addition, the
potency of 3-OH-DHP to block [ 35S]TBPS binding differed
between the two receptor subtypes in the absence of exogenous
GABA (Kd of 820  220 and 2460  160 nM respectively; p 
0.024). The latter result suggests that the affinity of1-containing
GABAARs for allosteric modulation with 3-OH-DHP is signif-
icantly higher than that of 2-containing receptors. However, to
study 3-OH-DHP modulation under more physiological con-
ditions, we also measured the potency of 3-OH-DHP to block
[ 35S]TBPS binding in the presence of 1 M exogenous GABA.
Under these conditions, no significant difference was observed
between the effects of 3-OH-DHP on the two receptor subtypes
(390 110 and 610 260 nM, respectively; p 0.4) (Fig. 1).
To test the effects of 3-OH-DHP on GABAAR ion channel
activity, we expressed the same receptor subtypes in Xenopus oo-
cytes. In these tests, no difference was detected between the two
receptor subtypes in the potentiation of GABA-induced (10 M)
whole-cell ionic currents by 100 nM 3-OH-DHP (14-fold in-
crease in both cases; n 4; data not shown). These data suggest
that rat GABAARs containing either the 1 or the 2 subunit are
similarly sensitive to the neurosteroid allopregnanolone.
GABAARs in1 subunit knock-out mice
To conclusively define whether in vivo the 1 subunit does con-
tribute to a higher affinity for neurosteroids than the 2 subunit,
the effect of neurosteroids on GABAARs needs to be studied
within the context of its subcellular environment (i.e., the
postsynaptic density at the GABA synapse) (Kneussel and Betz,
2000). To this end, we studied the effects of allopregnanolone on
GABAARs in the dorsomedial part of the SON of WT and 1
knock-out (1/) mice (Sur et al., 2001).
Real-time PCR analysis of 1 / versus WT SON samples
showed a complete lack of 1 subunit mRNA and no significant
compensatory regulation of any of the other subunits (Fig. 2A).
As a result, the relative contribution of 2 and 3 is larger in the
SON of1/ animals than in WT animals (Fig. 2B). Hence, in
1/mice, the2 and3 subunits may have a prominent role
in GABAAR formation. In situ whole-cell voltage-clamp record-
ings of dorsomedial SON neurons in adult female mice showed
that the decay time constant of sIPSCs in 1/mice was 35%
longer than in WT mice (Fig. 2C,F). This is in line with observa-
tions on cerebellar neurons in a different 1/mouse (Vicini
et al., 2001). We found that both WT and 1 / mouse SON
neurons express neurosteroid-sensitive GABAARs, i.e., in both
WT and 1 / animals, 3-OH-DHP significantly increased
sIPSC decay time constants (Fig. 2D,E,G). Thus, in mouse SON
neurons, lack of 1 subunit does not reduce the efficacy of allo-
steric modulation of GABAARs by 3-OH-DHP.
Neurosteroid sensitivity is dependent on signal
transduction pathways
If subunit composition of GABAARs cannot explain the endoge-
nous shift toward neurosteroid insensitivity in the SON, alterna-
tively, signal transduction pathways may play a substantial role.
Two changes in signal transduction pathways occur around par-
turition that can affect GABAARs. First, in contrast to the preg-
nant stage, at parturition and during lactation, a rise in the intra-
cellular calcium concentration may occur (Lambert et al., 1994)
as a result of endogenous oxytocin release (Neumann et al.,
1995). This may have numerous effects on postsynaptic signaling
routes targeted to GABAARs, which possibly involve Ca
2-
dependent kinases and phosphatases (De Koninck and Mody,
1996). For instance, PKC was shown to affect GABAAR activity in
SON cells after parturition (Brussaard et al., 2000). Second, the
role of serine/threonine (Ser/Thr) phosphatases 1, 2A, and 2B
(Price and Mumby, 1999), which are logical counterparts of PKC
in regulating GABAAR properties, may be larger during preg-
nancy than after parturition.
To address the first issue, we manipulated the free intracellular
calcium concentration and tested the effect on neurosteroid sen-
sitivity. Next, given the second issue, we also manipulated endog-
enous Ser/Thr phosphatase activity to test a presumed prerequi-
sitional role of this activity for conditional neurosteroid
sensitivity of GABAARs.
The role of Ca 2 was studied in juvenile (i.e., nonreproduc-
tive) male rats. For ethical reasons, we did not use reproductive
adult rats in these initial experiments. We titrated the free intra-
cellular calcium concentration, [Ca 2 ]i, to desired values by
altering the concentrations of EGTA/Ca 2 ratio in the pipette
solution. When recording from dorsomedial SON neurons, in
the absence of exogenous Ca 2 buffer in the pipette (i.e., the
unbuffered condition: 0 mM EGTA, 0 mM Ca 2), the average
decay time constant of sIPSCs was 18.9 1.5 msec, and 3-OH-
DHP significantly increased the sIPSC decay time constant (Fig.
3C,D). Remarkably, when [Ca 2]i was nominal zero by adding 1
mM EGTA (0 mM Ca 2), which by itself did not affect the decay of
sIPSC, there was no effect of 3-OH-DHP on the decay time of
IPSCs (Fig. 3A,D). In contrast, when [Ca 2]i was set at 10 nM (11
mM EGTA, 1 mM Ca 2), 3-OH-DHP strongly increased sIPSC
decay time constants (Fig. 3B,D). Also, in the latter condition,
Figure 1. Neurosteroid affinity of recombinant GABAARs containing1 or2 subunit. Two
distinct receptor compositions of the rat GABAAR were tested for their apparent affinity for
3-OH-DHP using a [ 35S]TBPS binding assay. 3-OH-DHP inhibited binding of the radioactive
ligand in a concentration-dependent manner. In the absence of GABA (top 2 traces), the appar-
ent affinity for 3-OH-DHP was significantly higher for1-containing receptors. However, in
the presence of GABA (1 M; bottom 2 traces), there was no such difference. All data were
normalized to the control [ 35S]TBPS binding in the absence of GABA and 3-OH-DHP.
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the sIPSC decay before application of 3-OH-DHP was not
different from control recordings in the unbuffered recording
condition. Thus, neurosteroid sensitivity of GABAARs in SON
neurons appeared to be dependent on [Ca 2]i.
Next, we recorded from SON neurons in nonreproductive
rats while Ser/Thr phosphatases were blocked using okadaic acid
and microcystin (specific blockers of phosphatases 1 and 2A) in
the pipette solution. These two drugs had no effect on decay time
constants by themselves. Unlike the endogenous condition of
GABAARs at this stage (Fig. 4A), okadaic acid (50 nM) and mi-
crocystin (100 nM) rendered GABAARs insensitive to subsequent
neurosteroid treatment (Fig. 4B,C,E). This implies that basal lev-
els of Ser/Thr phosphatase activity are of crucial importance for
modulation of GABAARs by 3-OH-DHP. In contrast, when
PKC was blocked using the specific PKC inhibitor chelerythrine
Figure 2. Effect of 3-OH-DHP in transgenic mice lacking GABAAR 1 subunit. A,  subunit
mRNA expression levels in the SON of1/ animals, normalized for the expression of-actin
mRNA and plotted relative to the expression of the WT levels (n 4). None of the subunits in1
/mice was significantly different from WT. B, Relative contribution of1 to6 to the total
subunit mRNA expression in1/and WT mice. C, Left, Average sIPSCs obtained in SON neurons
from WT and1/mice. Traces are averages of 100 sIPSCs per recording. The decay of sIPSCs was
fitted with a single-exponential function. Right, Histogram of the sIPSC decay time constants of exper-
iments shown on the left. D, Averaged sIPSCs recorded from WT in the absence and presence of
3-OH-DHP and decay time constant histogram showing a significant shift to the right in the pres-
ence of 3-OH-DHP. E, Average sIPSCs in the absence and presence of 3-OH-DHP and histogram of
sIPSC decay from an1/ recording showing a similarly large increase of decay by 3-OH-DHP.
F, Summary graph illustrating difference in sIPSC decay time constants between WT and1/
mice (WT, 19.51.1 msec, n14;1/, 26.31.3 msec, n15; p0.01; unpaired t test).
G, Summary graph showing 3-OH-DHP effects on the decay time constants (WT mice, significant
effect in 6 of 6 cells, Mann–Whitney U test, p 0.01, 256 111% of control; 1/ mice,
significant effect in 5 of 5 cells, Mann–Whitney U test, p 0.01, 181 52% of control). In none of
these conditions was the sIPSC amplitude significantly affected (data not shown). All other traces of
average sIPSCs were plotted normalized to the control average in C. Calibration (of the control trace),
20 msec, 40 pA.
Figure 3. Effect of 3-OH-DHP is dependent on [Ca 2]i in juvenile male rats (postnatal days
21–27). A, Left, Superimposed average sIPSCs obtained in SON neurons with [Ca 2]i at nominal
zero before and after 3-OH-DHP application. Right, sIPSCs decay time constant histogram of
this experiment. B, Average sIPSCs obtained in [Ca 2]i held at 10 nM in the absence and pres-
ence of 3-OH-DHP and histogram of sIPSC decay time constants. C, Average sIPSCs recorded
using unbuffered [Ca 2]i in the absence and presence of 3-OH-DHP and histogram of the
sIPSC decay time constants. D, Summary graph illustrating the relative effects of 3-OH-DHP on
sIPSC decay time constants at three dissimilar Ca 2 concentrations. Decay plotted as percent-
age of control values. White bars, Controls; gray bars, 3-OH-DHP. Relative neurosteroid effects
are as follows: [Ca 2]i at nominal zero, 108 3% of control, p 0.05, n 5; [Ca
2]i at 10
nM, 284 119% of control, p 0.05, n 6; unbuffered [Ca 2]i , 220 54% of control, p
0.05, n7. In none of these conditions was the sIPSC amplitude significantly affected (data not
shown). All other traces of average sIPSCs were plotted normalized to the control average in A.
Calibration (of the control trace), 20 msec, 100 pA.
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(1 M) in the pipette, sIPSC decay time constants were increased
during neurosteroid application to the same extent as in the con-
trol condition (Fig. 4D,E). PKC inhibition did not reduce neu-
rosteroid sensitivity at physiological temperature (33°C) either
(data not shown; decay time 252 58% of control; n 8).
Ser/Thr phosphatases determine neurosteroid sensitivity
during late pregnancy
Because GABAARs at the juvenile stage become insensitive to
3-OH-DHP when endogenous Ser/Thr phosphatases were
blocked, we hypothesized that a relative shift toward more phos-
phorylation would also reduce neurosteroid responsiveness of
GABAARs in the adult rat SON during parturition.
To test this, we first mimicked such a shift at P20 by inhibiting
Figure 4. Effect of 3-OH-DHP is dependent on Ser/Thr phosphatase activity in juvenile
male rats (postnatal days 21–27). B, C, Average sIPSCs in the absence and presence of 3-OH-
DHP and decay time constant histogram showing that inhibition of phosphatase activity by 50
nM okadaic acid ( A) or 100 nM microcystin ( B) prevents the effect of 3-OH-DHP. D, Average
sIPSCs and histogram of sIPSC decay time constants obtained in the presence of 1M cheleryth-
rine showing that PKC inhibition does not prevent the effect of 3-OH-DHP. E, Summary graph
illustrating the relative effects of 3-OH-DHP on sIPSC decay time constants in the four exper-
imental conditions. Decay plotted as percentage of control values. White bars, Controls; gray
bars, 3-OH-DHP. Relative neurosteroid effects are as follows: endogenous condition, 220
54% of control, p0.05, n7; 50 nM okadaic acid, 1154% of control, p0.05, n7; 100
nM microcystin, 105 6% of control, p 0.05, n 5; 1 M chelerythrine, 239 63% of
control, p0.05, n5. Okadaic acid (1043%; n7), microcystin (972%; n10), and
chelerythrine (99 8%; n 5) by themselves had no effect on sIPSC decay (unpaired t test;
p 0.05). In none of these conditions was the sIPSC amplitude significantly affected (data not
shown). All other traces of average sIPSCs were plotted normalized to the control average in A.
Calibration (of the control trace), 20 msec, 100 pA.
Figure 5. Experimental induction of neurosteroid resistance at late pregnancy. A, Left, Av-
erage sIPSCs obtained in SON neurons at P20 showing a large 3-OH-DHP effect under endog-
enous conditions using unbuffered pipette medium. Right, Histogram of the sIPSC decay time
constants of experiment shown on the left. B, Average sIPSCs in the absence and presence of
3-OH-DHP and histogram showing that phosphatase inhibition prevents 3-OH-DHP effect
on sIPSC decay. C, Average sIPSCs in the absence and presence of 3-OH-DHP and histogram
showing that PKC activation also prevents 3-OH-DHP effect on sIPSC decay. D, Summary graph
illustrating the relative effects of 3-OH-DHP on sIPSC decay time constants under the endog-
enous condition (to 196 31% of control; p 0.01; n 6), after phosphatase inhibition
(107 2%; p 0.05; n 6), and after PKC activation (108 6% compared with during TPA
pretreatment; p 0.05; n 7). TPA application did not affect sIPSC decay itself (104 3% of
control; p0.05; n6). However, it did significantly suppress the average sIPSC amplitude to
65 9% of control values ( p 0.05; n 6), which corresponds to previous findings in this
cell system (Brussaard et al., 2000). sIPSC decay was not different in okadaic acid (n  6)
compared with in experiments without the drug (n 22; 108 2%; unpaired t test; p
0.05). All other traces of average sIPSCs were plotted normalized to the control average in A.
Calibration (of the control trace), 20 msec, 100 pA.
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phosphatase activity (Fig. 5). GABAARs at P20 are very sensitive
to neurosteroids when using unbuffered pipette medium, as
shown by the 196 31% increase in decay time constant induced
by 3-OH-DHP (Fig. 5A,D), which is in line with previous re-
sults (Brussaard et al., 1997). This effect was completely absent
during a pretreatment with 100 nM okadaic acid (n  6) (Fig.
5B,D). The efficacy of this treatment was dose dependent, i.e., 50
nM okadaic acid reduced the effect of 3-OH-DHP in only three
of six cells (data not shown). Thus, at late pregnancy, as in juve-
niles, the constitutive activity of endogenous phosphatases is a
prerequisite for neurosteroid sensitivity of GABAARs.
Subsequently, we tested whether, at P20, 3-OH-DHP insen-
sitivity of GABAARs could also be induced by boosting endoge-
nous PKC activity instead of by suppressing phosphatase activity.
To this end, we used the phorbol ester TPA, which was applied to
the outside of the cell 3 min after the whole-cell configuration was
established. TPA (25 nM) by itself induced a reduction of the
average sIPSC amplitude to 65  9% of control, in line with
previous findings (Brussaard et al., 2000), but had no effect on the
sIPSC decay rate. More importantly, 3-OH-DHP no longer af-
fected sIPSC decay time constants after 8 min of TPA pretreat-
ment, showing also that an increase in endogenous phosphoryla-
tion activity renders GABAARs insensitive to neurosteroids (Fig.
5C,D).
Neurosteroid-insensitive mode of GABAARs
during parturition
Our next step was to test whether, after parturition, stimulating
dephosphorylation would restore 3-OH-DHP sensitivity of
GABAARs, to show that the determinant mechanism for neuro-
steroid effects on GABAARs is not endogenous shifts in subunit
composition but rather a conditional alteration in signal trans-
duction pathways. At PPD1, the decay of the sIPSCs was 24.6
1.1 msec (n 16) compared with 19.8 0.8 msec (n 22) at P20
( p 0.01; unpaired t test with Welch correction). This is in line
with previous work and is explained by the idea that at parturi-
tion a subunit switch from 1 to 2 occurs (Brussaard et al.,
1997).
Treatment with 3-OH-DHP had no effect on sIPSC decay at
PPD1 (Fig. 6A,E) (in line with Brussaard et al., 1997). To test
whether we could restore neurosteroid sensitivity, we first stim-
ulated endogenous Ser/Thr phosphatases in SON neurons with
C2-ceramide (10 M), an activator of phosphatases 2A and 1
(Yang, 2000). Before 3-OH-DHP treatment, we applied C2-
ceramide for 8 min to allow dephosphorylation to take place at
GABA synapses. There was no effect of C2-ceramide on IPSC
decay. However, 3-OH-DHP did potentiate GABA current de-
cay after C2-ceramide pretreatment, as shown by an increase to
190  45% of control values (Fig. 6B,E). Thus, by activation of
endogenous phosphatases in the SON after parturition, the
GABAAR responsiveness to 3-OH-DHP can be restored.
Next, we tested whether, at PPD1, PKC inhibition would also
rescue neurosteroid sensitivity. Chelerythrine (1 M), did not
affect sIPSC amplitude or decay but restored GABAAR respon-
siveness to 3-OH-DHP (Fig. 6C,E), as shown by the 207 40%
increase in decay time constant. This implied that, when PKC is
blocked, basal endogenous phosphatase activity suffices to rescue
3-OH-DHP sensitivity. This indicated that, under physiological
conditions, an increased level of phosphorylation activity is the
causal factor to determine 3-OH-DHP insensitivity in the SON
during parturition.
Subsequently, we went back to record from 1 / mice
SON neurons. These mice have a putative receptor subunit com-
Figure 6. Experimental rescue of neurosteroid sensitivity after parturition. A, Left, Average sIPSCs
obtained in SON neurons at PPD1 showing no effect of 3-OH-DHP under endogenous conditions.
Right, Histogram of the sIPSC decay time constants of this experiment. Filled circles are used for con-
trols, and open circles are for 3-OH-DHP. B, Average sIPSCs in the absence and presence of 3-OH-
DHPanddecaytimeconstanthistogramshowingshifttotherightwith3-OH-DHPafteractivationof
phosphatases by C2-ceramide. C, Average sIPSCs in the absence and presence of 3-OH-DHP and
histogramshowingthatPKCinactivationbychelerythrinerescues3-OH-DHPeffect.D,Recordingsin
1/ mice as a model for the postpartum stage in rats. Average sIPSCs and histogram from
experiment with okadaic acid showing that 3-OH-DHP sensitivity (compare with Fig. 2E) is depen-
dent on dephosphorylation. E, Summary graph illustrating the relative effects of 3-OH-DHP on IPSC
decay time constants under the endogenous condition (1096% of control; p0.05; n7), after
activationofphosphatases(19045%comparedwithduringC2-ceramidepretreatment;p0.05;
n9), and after PKC inhibition (20740% of control; p0.05; n7). In1/mice neurons
treated with okadaic acid, the neurosteroid effect on average was 1034% of controls ( p0.05;
in 4 of 4 cells). We observed no significant effect on the sIPSC decay of C2-ceramide (104 2% of
control; p 0.05; n 9). The sIPSC amplitude was unaffected by chelerythrine [275 36 pA
endogenouscondition(n21),32064pAinchelerythrine(n7);p0.05].Thelatter indicates
that the constitutive release of OT within the SON in not high enough to induce a suppression of the
sIPSC amplitude as was previously reported to occur with high concentrations of synthetic OT (Brus-
saard et al., 1996). sIPSC decay was not different in chelerythrine (n 7) compared with in experi-
ments without the drug (n16) (unpaired t test; p0.05). All sIPSC traces were normalized to the
control amplitude level. In none of these conditions was the sIPSC amplitude significantly affected
(data not shown). All other traces of average sIPSCs were plotted normalized to the control average in
A. Calibration (of the control trace), 20 msec, 100 pA.
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position in the SON (Fig. 2B) that can be compared with that of
rats at the postpartum state (Brussaard et al., 1997). However,
they do not show neurosteroid resistance and are in fact very
sensitive to 3-OH-DHP (Fig. 2E,G). We argued that, as in rats
at the juvenile or adult pregnant stage, also in 1 / mice a
relatively higher level of endogenous dephosphorylation activity
may be responsible for the neurosteroid sensitivity. Hence, we
recorded SON neurons in 1 / mice while blocking Ser/Thr
phosphatases with okadaic acid. This treatment induced
GABAAR insensitivity to 3-OH-DHP (Fig. 6D,E). This conclu-
sively showed that, regardless of the GABAAR subunit composi-
tion, i.e., with or without 1, it is the balance between phosphor-
ylation and dephosphorylation that determines their sensitivity
to neurosteroid.
Oxytocin causes neurosteroid-insensitive state of GABAAR
To find the physiological trigger that caused the shift in the bal-
ance between phosphatase and PKC activity at parturition, we
tested whether the neurosteroid-resistant mode of GABAARs of
oxytocin neurons in the SON is brought about by activation of
oxytocin autoreceptors. We applied oxytocin (5 M) at P20 and
the peptidergic receptor antagonist dOVT (4M) at PPD1 during
an 8 min pretreatment period. Application of OT in experiments
on late pregnant rats by itself decreased sIPSC amplitudes as ex-
pected (Brussaard et al., 1996, 2000) but had no significant effect
on sIPSC decay (data not shown). However, after oxytocin pre-
treatment, the normally observed effect of 3-OH-DHP on
sIPSCs was prevented (Fig. 7A,C). Application of receptor antag-
onist dOVT during sIPSC recordings in PPD1 by itself had no
significant effects on either sIPSC amplitude or decay (Fig. 7
legend). Subsequent application of 3-OH-DHP increased decay
time constants (Fig. 7B), which is in sharp contrast to the endog-
enous condition of the GABAAR neurosteroid sensitivity at this
stage (Fig. 7C). This implied that constitutive OT release within
the SON (Leng et al., 1999) after parturition prevents 3-OH-
DHP potentiation of GABA currents via activation of the oxyto-
cin receptor. This effect occurred already at basal extracellular
concentrations of OT after parturition and was therefore inde-
pendent of sIPSC amplitude reduction observed only at higher
concentrations of OT (Brussaard et al., 1996).
Discussion
We propose that the naturally occurring reduction in neuroste-
roid sensitivity of the GABAAR in SON neurons after parturition
is brought about by increased levels of phosphorylation and not,
as we proposed previously (Brussaard and Herbison, 2000), by
subunit composition of the GABAAR. Our data indicate that the
extent of oxytocin receptor activation is the main determinant of
PKC activity and GABAAR sensitivity to allopregnanolone in the
SON. In lactating females that normally have high oxytocin levels
and allopregnanolone-resistant GABAARs, we were able to re-
store neurosteroid sensitivity by pretreating the SON with an
oxytocin receptor antagonist. Conversely, before parturition,
when oxytocin levels in the SON are low (Leng et al., 1999) and
GABAARs are sensitive to neurosteroid (Brussaard et al., 1997),
application of oxytocin rendered GABAARs completely insensi-
tive to allopregnanolone within minutes. These results are fully
consistent with the functional significance of GABAAR plasticity
in the oxytocin neuron (Brussaard and Herbison, 2000).
Neurosteroid sensitivity of GABAARs in the SON does not
depend on subunit composition
Previously, it was reported that 1-containing GABAARs are six-
fold to 10-fold more sensitive to allopregnanolone than 2-
containing receptors in oocytes (Belelli et al., 1996). However,
neurosteroids do bind with high specificity to the 2 subunit
(Rick et al., 1998). Similarly, inclusion of 6 appeared to increase
neurosteroid sensitivity (Hauser et al., 1995), whereas the 4
subunit is associated with a decrease in both neurosteroid and
benzodiazepine sensitivity (Smith et al., 1998a,b). In addition,
the reduced sensitivity of native GABAARs to neurosteroids dur-
ing neonatal development of granule neurons in culture was
partly attributed to a increase of  subunit expression (Zhu et al.,
1996). Also, our group has put forward the idea of subunit com-
position dependence of GABAAR neurosteroid sensitivity (Brus-
saard and Herbison, 2000). Nonetheless, at this moment, there is
no unifying theory of the involvement of GABAAR subunit com-
position to explain the physiological regulation of allosteric re-
Figure 7. Oxytocin autoregulation renders GABAARs insensitive to neurosteroid. A, Left, Su-
perimposed average sIPSCs before and after 3-OH-DHP application obtained in SON neurons
at P20 pretreated with OT. Right, Decay time constant histogram of this experiment. B, Average
sIPSCs in the absence and presence of 3-OH-DHP and decay time constant histogram showing
large 3-OH-DHP effect at PPD1 after block of oxytocin autoreceptors. C, Summary graph illus-
trating the dependence of the neurosteroid effect on oxytocin receptor activity. Decay plotted as
percentage of controls. White bars, Control; gray bars, 3-OH-DHP. Notice the differences with
the endogenous condition at both stages. After OT pretreatment, 3-OH-DHP did not affect
sIPSC decay time constants (104 5% compared with during OT pretreatment; p 0.05; n
6). OT by itself had a small but nonsignificant effect on sIPSC decay time constants (114 7%
of control; p0.05; n8). As expected, OT decreased sIPSC amplitudes (6813% of control;
p 0.05; n 8). At PPD1, 3-OH-DHP increased sIPSC decay time constants after OT antag-
onist (224 26% compared with during OT antagonist pretreatment; p 0.05; n 5). OT
antagonist by itself had no effect on sIPSC decay (109 5% of control; p 0.05; n 5). OT
antagonist had no effect on sIPSC amplitude (96 19%; n 5). All other traces of average
sIPSCs were plotted normalized to the control average in A. Calibration (of the control trace), 20
msec, 100 pA.
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ceptor modulation by neurosteroids. Here we exclude a role for
1–2 subunit switching, which is known to occur in the SON
after parturition and which correlates with a transient decrease in
receptor neurosteroid sensitivity (Brussaard et al., 1999). Our
measurements in 1 knock-out animals show that receptor sub-
unit switching of native receptors is very unlikely to be the direct
cause of a reduction in neurosteroid sensitivity of the GABAAR in
SON neurons.
Phosphorylation events determine neurosteroid sensitivity of
GABAARs in the SON
Most likely the sensitivity of GABAARs to allopregnanolone in
SON neurons during late pregnancy is brought about by a con-
stitutive high level of endogenous phosphatase activity. Vice
versa, after parturition, when GABAARs are insensitive to neuro-
steroids, inhibition of PKC or stimulation of endogenous phos-
phatases restored allopregnanolone sensitivity. Moreover, a con-
stitutive level of oxytocin appears to be maintained under basal
conditions at this stage, because blocking putative oxytocin ef-
fects with an antagonist readily brought about the normal sensi-
tivity of GABAARs to allopregnanolone.
This implies that phosphatases and PKC may have converging
effects, possibly acting on the same Ser/Thr residue of the 2, 3,
or 2 GABAAR subunit (McDonald and Moss, 1997). Alterna-
tively, PKC and phosphatases may act on different phosphoryla-
tion sites or even on different proteins of the postsynaptic density
of the GABA synapse (Kneussel and Betz, 2000), including the
GABAAR-interacting protein RACK-1 (receptor for activated C
kinase-1) (Brandon et al., 1999; Feng et al., 2001). In addition,
phosphatase-targeting proteins like spinophilin (Hsieh-Wilson
et al., 1999) or the scaffold protein AKAP79 (A kinase anchor
protein 79) that binds both PKC and phosphatase 2B (Klauck et
al., 1996) may be involved in the local regulation of phosphory-
lation cascades.
The putative role of the above proteins in or near the postsyn-
aptic density may explain the discrepancy between the regulation
of allopregnanolone sensitivity described in native synapses and
of GABAARs expressed in oocytes (Leidenheimer and Chapell,
1997). In addition, in oocyte experiments, the effect of neuro-
steroids is on slow desensitization of GABAAR activity rather than
on ion channel mechanisms involved in the decay of synaptic
currents, i.e., receptor deactivation and fast desensitization
(Jones and Westbrook, 1995). Because fast desensitization of
the postsynaptic GABAAR channels can keep the receptor pro-
tein in an agonist-bound state, thereby slowing the rate of final
ion channel closure during the synaptic decay, it is very likely
that neurosteroids slow the recovery of the GABAAR from the
desensitized state and in this way prolong synaptic current
decays (Zhu and Vicini, 1997). Hence, we cannot exclude that
distinct neurosteroid effects on GABAARs do occur that are
different in their sensitivity to endogenous shifts in the bal-
ance of phosphorylation.
In addition to a putative phosphorylation-dependent regula-
tion of the effect of an allosteric modulator, direct effects of phos-
phorylation of residues of  and  subunit on desensitization
properties of GABAAR channels have been reported previously
(Krishek et al., 1994). Decay time constants of sIPSCs may be
affected by alterations in protein kinase or phosphatase activity,
such as reported for hippocampal neurons (Jones and West-
brook, 1997; Poisbeau et al., 1999).
Specificity of experimental interference with balance of PKC
and phosphatase activity
It was proposed previously that PKC activation rather than PKC
inhibition is required for allopregnanolone potentiation of the
synaptic currents in the juvenile SON (Fancsik et al., 2000). How-
ever, we would argue that these previous experiments depended
to some extent on the specificity of one PKC inhibitor, bisindolyl-
maleimide. This substance enhanced sIPSC decay already in the
absence of neurosteroid (132.5% of control) (Fancsik et al.,
2000), complicating the interpretation of the effect of subsequent
neurosteroid treatment. We also observed that bisindolylmale-
imide at a concentration of 500 nM, in the absence of neuroste-
roid, significantly potentiates the sIPSC decay (data not shown).
Instead, we used chelerythrine (1M), which did not affect the
sIPSC decay in SON neurons by itself. In the neurosteroid-
resistant condition after parturition, PKC inhibition by chel-
erythrine clearly shifted the GABAARs toward the neurosteroid-
sensitive mode (Fig. 6). In contrast, in neurosteroid-sensitive
nonreproductive animals, chelerythrine did not reduce neuroste-
roid effects, at neither room temperature (Fig. 4) nor 33°C (Fig. 4
legend).
To further substantiate our findings that PKC inhibition,
rather than activation, renders GABAARs in the SON sensitive to
allopregnanolone, we also performed the reverse experiment and
blocked endogenous phosphatase activity in both juvenile and
late pregnant rats. Again, we first tested the specificity of the
phosphatase inhibitors. Both okadaic acid (50 –100 nM) and mi-
crocystin (100 nM) did not affect the sIPSC decay in the absence
of neurosteroid, whereas at high concentrations such blockers
might affect GABA currents in other brain regions (Nusser et al.,
2001). Subsequently, as expected from the PKC inhibition re-
sults, we found that, before parturition, both inhibitors shifted
the neurosteroid-sensitive GABAARs toward the neurosteroid-
insensitive mode (Figs. 4, 5). Moreover, activation of endogenous
phosphatase activity after parturition, using C2-ceramide, rescued
neurosteroid sensitivity of GABAARs after parturition (Fig. 6).
A model of regulation of GABAAR activity before and
after parturition
During pregnancy, allopregnanolone levels are high (Concas et
al., 1998), there is little oxytocin secretion (Leng et al., 1999), and
basal oxytocin levels are low attributable to significant break-
down by aminopeptidases (Kombian et al., 1997). GABAARs at
that stage are occupied by endogenous allopregnanolone, which
results in a slower decay of synaptic current responses (Brussaard
et al., 1997), and prevents putative PKC modulation (Brussaard
et al., 2000). Intracellular [Ca 2] under these conditions is43
nM (Lambert et al., 1994), which apparently favors endogenous
phosphatase activity over PKC activity (this report). Thus, all
conditions in the SON during pregnancy are aimed at keeping
oxytocin neurons silent.
Before parturition, allopregnanolone levels abruptly drop
(Concas et al., 1998), and the somatodendritic release of oxytocin
goes up dramatically. Oxytocin receptor activation then results in
increased PKC activity attributable to activation of the phospho-
lipase C–IP3–DAG pathway, and release from allopregnanolone
modulation will allow GABAARs to be influenced by this PKC
activity (Brussaard et al., 2000). Moreover, an additional increase
in [Ca 2] may be expected from the increase in firing rate and the
concomitant transient calcium flux via voltage-gated calcium
channels. Thus, altered conditions around parturition allow the
SON system to be relieved from inhibition by at least two com-
plementary cellular mechanisms: (1) reduced allosteric GABAAR
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potentiation attributable to removal of endogenous allopreg-
nanolone, and (2) reduced GABAAR sensitivity toward allopreg-
nanolone attributable to increased phosphorylation at the
postsynaptic density.
Physiological significance of allosteric GABAAR modulation
Although the important functions of allopregnanolone become
particularly clear during the female reproduction cycle, levels of
allopregnanolone are also known to rise transiently in relation to
acute stress (Purdy et al., 1991). Neurosteroid modulation of
GABAARs has been associated with phenomena such as memory
formation, anxiety, sleep, depression, seizure-like activity (Ma-
jewska, 1992), postpartum blues (Nappi et al., 2001), and mood
swings during the menstrual cycle (Smith et al., 1998a,b). Thus,
studying the molecular mechanism underlying regulation of neu-
rosteroid sensitivity of postsynaptic GABAARs is important and
may lead to the further development of neurosteroid-related
compounds for use as improved anxiolytic drugs with a reduced
risk of tolerance as an alternative to benzodiazepines (Rupprecht
and Holsboer, 1999). In addition, GABAAR susceptibility to eth-
anol is altered in transgenic mice lacking particular PKC isomers
(Hodge et al., 1999). Hence, metabotropic control over allosteric
modulation of GABAARs may be a general phenomenon that
regulates the efficacy of GABA synapses throughout the brain.
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